Cargando…

Construction and Validation of a Novel Immune-Related Gene Pairs-Based Prognostic Model in Lung Adenocarcinoma

OBJECT: Focus on immune-related gene pairs (IRGPs) and develop a prognostic model to predict the prognosis of patients with lung adenocarcinoma (LUAD). METHODS: First, the LUAD patient dataset was downloaded from The Cancer Genome Atlas database, and paired analysis of immune-related genes was subse...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Yafeng, Zhou, Jiawei, Wu, Jing, Zhang, Xin, Guo, Jianqiang, Xing, Yingru, Xie, Jun, Bai, Ying, Hu, Dong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2023
Materias:	Original Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9834935/ https://www.ncbi.nlm.nih.gov/pubmed/36625357 http://dx.doi.org/10.1177/10732748221150227

Ejemplares similares

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode
por: Jiawei, Zhou, et al.
Publicado: (2020)

Identification of Key Genes Driving Tumor Associated Macrophage Migration and Polarization Based on Immune Fingerprints of Lung Adenocarcinoma
por: Wu, Jing, et al.
Publicado: (2021)

Systematic construction and validation of an immune prognostic model for lung adenocarcinoma
por: Luo, Chenghan, et al.
Publicado: (2019)

An immune indicator based on BTK and DPEP2 identifies hot and cold tumors and clinical treatment outcomes in lung adenocarcinoma
por: Han, Tao, et al.
Publicado: (2023)

Development and Validation of Machine Learning Models to Predict Epidermal Growth Factor Receptor Mutation in Non-Small Cell Lung Cancer: A Multi-Center Retrospective Radiomics Study
por: Liu, Yafeng, et al.
Publicado: (2022)

Construction and Verification of a Radiation Pneumonia Prediction Model Based on Multiple Parameters
por: Yafeng, Liu, et al.
Publicado: (2021)

Relationship Between Neutrophil-To-Lymphocyte Ratio and Brain Metastasis in Non-Small Cell Lung Cancer Patients
por: Hu, Chunxiao, et al.
Publicado: (2022)

Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature
por: Qi, Xiangjun, et al.
Publicado: (2021)

Surgical Treatment is Still Recommended for Patients Over 75 Years with IA NSCLC: A Predictive Model Based on Surveillance, Epidemiology and End Results Database
por: Zhang, Wenting, et al.
Publicado: (2022)

Long-Term Exposure to Dust and Noise Can Increase the Risk of Hypertension—A Population Based, Cross-sectional Study
por: Guo, Jianqiang, et al.
Publicado: (2023)

Development and validation of an immune‐related prognostic signature in lung adenocarcinoma
por: Sun, Sijin, et al.
Publicado: (2020)

Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma
por: Li, Wanzhen, et al.
Publicado: (2021)

Construction and validation of an angiogenesis-related lncRNA prognostic model in lung adenocarcinoma
por: Gong, Quan, et al.
Publicado: (2023)

Construction and validation of a novel ferroptosis-related prognostic signature for lung adenocarcinoma
por: Yang, Li, et al.
Publicado: (2023)

Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer
por: Xu, Minxian, et al.
Publicado: (2022)

Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma
por: Yin, Zhengrong, et al.
Publicado: (2022)

Construction of an immune-related lncRNA pairs model to predict prognosis and immune landscape of lung adenocarcinoma patients
por: Liu, Junhui, et al.
Publicado: (2021)

A novel prognostic signature of immune-related lncRNA pairs in lung adenocarcinoma
por: Liu, Yang, et al.
Publicado: (2021)

Construction and Validation of an Immune-Based Prognostic Model for Pancreatic Adenocarcinoma Based on Public Databases
por: Mao, Miaobin, et al.
Publicado: (2021)

Construction of an immune-related lncRNA signature pair for predicting oncologic outcomes and the sensitivity of immunosuppressor in treatment of lung adenocarcinoma
por: Zhuang, Jinman, et al.
Publicado: (2022)

Receptor–ligand pair typing and prognostic risk model of response or resistance to immune checkpoint inhibitors in lung adenocarcinoma
por: Mao, Shengqiang, et al.
Publicado: (2023)

Construction of the optimization prognostic model based on differentially expressed immune genes of lung adenocarcinoma
por: Zhai, Yang, et al.
Publicado: (2021)

Construction of a Prognostic Immune-Related LncRNA Risk Model for Lung Adenocarcinoma
por: Li, Yue, et al.
Publicado: (2021)

Construction of an STK11 Mutation and Immune-Related Prognostic Prediction Model in Lung Adenocarcinoma
por: Tang, Bo, et al.
Publicado: (2023)

Construction and validation of a novel prognostic model of neutrophil‑related genes signature of lung adenocarcinoma
por: Zhu, Qianjun, et al.
Publicado: (2023)

Identification of Differentially Expressed and Prognostic lncRNAs for the Construction of ceRNA Networks in Lung Adenocarcinoma
por: Cui, Yimeng, et al.
Publicado: (2021)

Hypoxia Constructing the Prognostic Model of Colorectal Adenocarcinoma and Related to the Immune Microenvironment
por: Zhang, Yuanyuan, et al.
Publicado: (2021)

Construction and validation of a prognostic model for lung adenocarcinoma based on endoplasmic reticulum stress-related genes
por: Li, Feng, et al.
Publicado: (2022)

Identification and validation of novel lung adenocarcinoma subtypes and construction of prognostic models: based on cuprotosis-related genes
por: Wang, Guangyao, et al.
Publicado: (2023)

Identification and Validation of Immune-Related LncRNA Prognostic Signature for Lung Adenocarcinoma
por: Wu, Guomin, et al.
Publicado: (2021)

Development and Validation of a Combined Hypoxia and Immune Prognostic Classifier for Lung Adenocarcinoma
por: Huang, Hua, et al.
Publicado: (2022)

Development and validation of a combined metabolism and immune prognostic model in lung adenocarcinoma
por: Shi, Yu, et al.
Publicado: (2022)

Development and validation of a combined ferroptosis and immune prognostic signature for lung adenocarcinoma
por: Li, Han, et al.
Publicado: (2022)

Construction and validation of a novel prognostic nomogram for predicting overall survival in lung adenocarcinoma patients with different patterns of metastasis
por: Xiong, Ying, et al.
Publicado: (2023)

Development and validation of a MUC16 mutation-associated immune prognostic model for lung adenocarcinoma
por: Liu, Honggang, et al.
Publicado: (2023)

Construction and validation of a hypoxia-related risk signature identified EXO1 as a prognostic biomarker based on 12 genes in lung adenocarcinoma
por: Chen, Qirui, et al.
Publicado: (2023)

Identification of New Prognostic Genes and Construction of a Prognostic Model for Lung Adenocarcinoma
por: Chen, Xueping, et al.
Publicado: (2023)

Construction and validation of an immunity-related prognostic signature for breast cancer
por: Zhu, Tao, et al.
Publicado: (2020)

Establishment of Immune-related Gene Pair Signature to Predict Lung Adenocarcinoma Prognosis
por: Jiang, Xueping, et al.
Publicado: (2020)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m1aspcebqr041o5g611u31vesi